Core Viewpoint - China Life Insurance (02628.HK) is experiencing a strong upward trend in its stock price, currently at 17.16 HKD, reflecting a 1.06% increase, following a rebound from a short-term support level of 16.2 HKD [1] Technical Analysis - The stock price has surpassed all major technical moving averages, including the 10-day moving average at 16.4 HKD, the 30-day moving average at 15.63 HKD, and the 60-day moving average at 15.23 HKD, indicating a bullish structure [1] - The stock is approaching the first resistance level at 17.3 HKD, with a potential target of 18.3 HKD if this level is breached [2] - The recent volatility is reflected in a 6.8% fluctuation over five days, with an RSI index at 72, indicating a technical overbought condition [3] - The overall technical indicators are rated as "strong buy," with a signal strength of 16 points, supported by bullish momentum across all categories [3] - The MACD has completed a golden cross and maintains an expanding trend, supporting a continued upward pattern [3] - The price has successfully broken through the Ichimoku cloud, suggesting further upward potential in the coming weeks [3] Derivative Products Performance - On June 6, China Life's related structured products performed well, with a 2.76% increase in the underlying stock, leading to significant gains in derivatives [4] - The Societe Generale bull certificate (53998) led with a 15% increase, outperforming the underlying stock, showcasing the leverage advantage of bull certificates in rising markets [4] Investment Options - Current market conditions provide diverse investment options through China Life's related structured products, with call options offering a leverage of 4.1 times [7] - Bull certificates from HSBC (53706) and JPMorgan (53835) offer over 5 times actual leverage, with a buyback price set at 14 HKD [7] - For bearish strategies, Citigroup's bear certificate (56865) offers a leverage of 4.7 times, with a buyback price set at 20 HKD, providing a favorable risk-reward ratio [7] Summary - China Life is in a healthy upward phase with strong volume-price support and trend indicator resonance, but caution is advised due to potential overbought conditions and divergence risks [10]

Group 1 - Zhaojin Mining (01818) has shown strong recent performance, with technical indicators suggesting continued upward momentum in the short term. As of 11:30 AM, the latest price was HKD 20.15, up 2.7%, with the 10-day moving average (HKD 18.3) crossing above the 30-day moving average (HKD 18.01), forming a "golden cross" that reflects a positive short-term trend [1] - The Relative Strength Index (RSI) is at 67, nearing the overbought zone but not extreme, while the MACD shows a "buy" signal. The Bollinger Bands are expanding, indicating potential increased volatility. Key support levels are at HKD 18.6 and HKD 17.8, with resistance at HKD 20.9 and HKD 21.7. A breakthrough above HKD 20.9 could challenge higher levels [1] - The leverage effect of warrants has amplified returns, with Zhaojin Mining's stock price rising 8.76% on May 19, leading to significant gains in related warrants. Morgan Stanley's call option (27406) and UBS's call option (27337) recorded increases of 27% and 29%, respectively, exceeding the stock's rise by more than three times [4] Group 2 - Investors optimistic about Zhaojin Mining's potential to break through the HKD 20.9 resistance should consider longer-dated slightly out-of-the-money call options to balance time decay and leverage benefits. Current call options have varied terms, with exercise prices concentrated around HKD 18 and HKD 30. For instance, in-the-money products like Morgan Stanley's call option (27839) and UBS's call option (27337) have a leverage of 2.8 times, while out-of-the-money products have a leverage exceeding 3.3 times, with expiration dates in late November [7] - The market sentiment around Zhaojin Mining is influenced by strong gold prices and a robust technical outlook, although the RSI and Williams indicators are approaching overbought levels, raising questions about potential profit-taking in the short term. Investors are encouraged to share their strategies regarding whether to opt for warrants or directly purchase the underlying stock [10]